3D Alginate Hydrogel Tumor Models for Drug Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current two-dimensional cell culture methods fail to accurately replicate the microenvironmental conditions of tumors in vivo, leading to limitations in preclinical testing of anti-cancer drugs, with issues such as reproducibility and batch-to-batch variations, and lack of representation of elastic moduli typical of tumors.

Innovation Solution

A three-dimensional cell culture system using alginate-based hydrogels that incorporate cells, allowing for the recreation of biomimetic tumor microenvironments with controlled elastic moduli and the ability to perform high-throughput drug screening, including heterotypic models of breast cancer.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If two-dimensional cell culture in plastic dishes is used, then ease of operation is improved, but biological relevance to in vivo tumor conditions deteriorates

Engineering Contradiction:
Improveease of operationVSAvoidbiological relevance
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent transitions from two-dimensional cell culture in plastic dishes to three-dimensional cell culture in hydrogel beads. This dimensional change enables cells to experience more realistic microenvironmental conditions including cell-cell and cell-extracellular matrix interactions in three dimensions, thereby improving biological relevance while maintaining operational feasibility through automated dispensing systems

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If Matrigel systems are used for three-dimensional cell culture, then biological relevance is improved, but manufacturing precision deteriorates due to batch-to-batch variations

Engineering Contradiction:
Improvebiological relevanceVSAvoidmanufacturing precision
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent changes the material parameter from natural Matrigel to synthetic or natural hydrogels with defined chemical compositions and controlled physical properties. These hydrogels allow precise control over elastic moduli to match tumor tissue stiffness and enable reproducible batch-to-batch manufacturing while maintaining three-dimensional culture benefits

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite hydrogel materials that can be engineered to provide both the desired three-dimensional microenvironment and reproducible manufacturing characteristics. The hydrogels can be formulated with specific crosslinking densities and compositional ratios to achieve target mechanical properties consistently across batches

Inventive Principle:
Principle #40Composite materials

3Reliability

If three-dimensional cell culture systems are developed to replicate tumor microenvironments, then biological relevance is improved, but device complexity increases

Engineering Contradiction:
Improvebiological relevanceVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the complex task of creating three-dimensional tumor microenvironments into discrete hydrogel beads of standardized sizes. Each bead serves as an independent microenvironmental unit that can be manufactured, stored, and dispensed separately, simplifying the overall system architecture and enabling high-throughput screening formats

Inventive Principle:
Principle #1Segmentation

4Manufacturing precision

If reproducible three-dimensional cell culture systems with controlled elastic moduli are created, then manufacturing precision is improved, but ease of manufacture deteriorates

Engineering Contradiction:
Improvemanufacturing precisionVSAvoidease of manufacture
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent employs self-assembling hydrogel formulations that automatically form beads with controlled elastic moduli through defined chemical crosslinking mechanisms. The hydrogels self-organize into uniform three-dimensional structures when exposed to crosslinking agents, eliminating the need for complex external manufacturing equipment while achieving precise mechanical property control

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS9097702B2Pathologically relevant tumor microenvironments for high-throughput drug screening
Publication Date: 2015.08.04 CORNELL UNIVERSITY
  • US9097702B2 patent drawing
  • US9097702B2 patent drawing
  • US9097702B2 patent drawing

AI summary

A three-dimensional cell culture system is provided comprising one or more cell types of interest incorporated in a natural or synthetic hydrogel. An apparatus for high-throughput drug screening is also provided comprising a plurality of three-dimensional cell culture systems and a dispenser for placing at least one three-dimensional cell culture system into a pre-determined well of a multiwell plate. A method for high-throughput drug screening is also provided that comprises providing a test agent, providing a three-dimensional cell culture system, determining a first cellular response of the cell of interest before culturing in the presence of the agent, culturing the cell of interest in the cell culture system in the presence of the agent, determining a second cellular response of the cell of interest after culturing in the presence of the agent, and comparing the first and second cellular responses.